Navigation Links
Filtrona Porous Technologies Realizes Innovative New Product Development Through Foam-Fiber Technology Synergy : Introducing MediSponge(R) RBR Wound Care Dressings
Date:11/4/2009

RICHMOND, Va., Nov. 4 /PRNewswire-FirstCall/ -- Filtrona Porous Technologies, manufacturer of custom fluid handling fiber and foam components for the medical device and healthcare industry, and a division of UK-based Filtrona plc (Pink Sheets: FLRAF), has recently developed a unique foam-fiber hybrid component for select medical and personal care markets, specifically wound care. Referred to as MediSponge® RBR, the patent-pending foam-fiber composite consists of a soft, highly absorbent foam with hydrophilic properties structurally enhanced by the addition of a fiber matrix. The development represents yet another innovation by Filtrona Porous Technologies in the area of specialty healthcare industry products.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081017/NEF038LOGO )

Hydrophilic foam's presence as a wound dressing material has increased dramatically the last several years, featuring prominently in select advanced wound care settings. MediSponge RBR now expands the technology's application range within this market. To date, one delimiting characteristic of hydrophilic foam is its tensile and structural strength when wet, especially when exposed to moist or damp conditions for a substantial period of time. This consideration has mitigated the media's full potential with longer-term, advanced wound applications desirous of reduced dressing changes, even including, when combined with its expansive properties, some negative pressure therapy environments.

Filtrona's new MediSponge RBR overcomes these limitations. MediSponge RBR incorporates to the foam media a fiber matrix that acts as a reinforcement or rebar-like structural enhancement. Versus the standard wet hydrophilic foam material, the average tensile strength, tear strength, and expansion properties may be improved by as much as 600 times, 40 times, and near 2 times respectively. These product technology enhancements among others make it an ideal material to consider for foam dressing applications for long-term advanced wound care.

In late 2008 Filtrona united the fiber and foam technology divisions under the Porous Technologies umbrella with the intent to bring customers unique solutions from a variety of base porous media. This foam-fiber composite innovation behind MediSponge RBR exemplifies Filtrona Porous Technologies' expertise with applications development for select market needs.

About Filtrona Porous Technologies

Based in Richmond, Virginia USA, Filtrona Porous Technologies (www.filtrona-fpt.com) is a leading manufacturer of customized bonded fiber and hydrophilic foam components for fluid and vapor handling used in consumer, medical and industrial products. Filtrona Porous Technologies has manufacturing locations in North America, Europe and Asia, and is a division of Filtrona plc, a global specialty plastic and fiber products supplier based in the United Kingdom.

SOURCE Filtrona Porous Technologies


'/>"/>
SOURCE Filtrona Porous Technologies
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy
2. Leading Event for People With Disabilities on November 6-8 Features Latest Technologies, Products, Services, and More
3. Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies and Markets
4. China Medical Technologies to Hold its Annual General Meeting on November 16, 2009
5. Palatin Technologies to Present at 8th Annual BIO Investor Forum
6. Wound Management Technologies (OTCBB- WNDM) Signs Biotech Agreement With Biocure S.r.l. of Milan, Italy
7. BioStorage Technologies, Inc., Accelerates European Expansion with Opening of New German Facility
8. Timm Medical Technologies and Ferring Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Prosed(R) DS
9. Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington, D.C.
10. Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference
11. Noninvasive Medical Technologies Awarded ISO 13485 Quality Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... Research and Markets has announced the addition ... EU Markets"  report to their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... the current Positron Emission Tomography (PET) scanner and cyclotron install ... includes France , Germany ... and the United Kingdom . Along ...
(Date:5/4/2016)... Holdings (NYSE: CODI ) ("CODI," "we," "our" ... businesses, announced today its consolidated operating results for the ... Quarter 2016 Highlights , Generated Cash Flow Available ... $13.6 million for the first quarter of 2016; ... first quarter of 2016; , Paid a first ...
(Date:5/4/2016)... JERUSALEM , May 4, 2016 ... University of Jerusalem announced today that it had ... BioTheryX, Inc. , developer of novel protein degradation ... the development and commercialization of drug candidates representing first-in-class ... the license were not disclosed. The novel ...
Breaking Medicine Technology:
(Date:5/6/2016)... ... 06, 2016 , ... Logically, spring weather, with its moderate humidity and temperatures, ... cold, dry or hot, water on the eye surface can evaporate, creating uncomfortable dry ... air. There’s only one problem, according to radio show and water advocate Sharon Kleyne: ...
(Date:5/6/2016)... ... , ... Canadian author Mark Black is a speaker, author, and life strategy coach ... world … with the help of his publisher Strategic Book Group and its subsidiary ... hospital bed waiting for a miracle: He needed a heart and double-lung transplant. From this ...
(Date:5/6/2016)... , ... May 06, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... worldwide, what he has found in the Bible about helping to stop cancer. Yisrayl says ... it is his hope that the health and science industries will pay close attention and ...
(Date:5/6/2016)... ... 2016 , ... Kenneth Cochran, DSc, RN, FACHE, President/CEO of ... South announced today that Dr. Robert Menuet, Interventional Cardiologist with Cardiovascular Institute of ... Coronary Atherectomy. , This procedure involves the removal of plaque by ...
(Date:5/5/2016)... Tucson, AZ (PRWEB) , ... May 05, 2016 , ... ... more attention being paid to the impact our aging population has on communities and ... help aging adults plan for and face age-related challenges. , Aging Life Care ...
Breaking Medicine News(10 mins):